ED
TECH icon

Exane Derivatives’s Bio-Techne TECH Stock Holding History

Exane Derivatives’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$141K Hold
1,628
– – 0.08% 224
2022
Q1 		$176K Buy
+1,628
New +$168K 0.05% 369

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Exane Derivatives's TECH Position: Q2 2022 in Review

Exane Derivatives held its Bio-Techne (TECH) position steady in Q2 2022 at 1,628 shares worth $141K. The position accounts for 0.08% of the portfolio, ranked #224.

Exane Derivatives first reported a position in TECH in Q1 2022 and has held it in 2 quarters since. The position peaked at $176K in Q1 2022. 550 funds tracked by Wall St. Rank hold TECH as of Q2 2022.

  • Exane Derivatives held 1,628 shares of Bio-Techne worth $141K as of Q2 2022.
  • Exane Derivatives left its Bio-Techne share count unchanged in Q2 2022.
  • Bio-Techne made up 0.08% of Exane Derivatives's portfolio in Q2 2022, its #224 holding.
  • Exane Derivatives first reported a position in Bio-Techne in Q1 2022 and has held it in 2 quarters since.
  • Exane Derivatives's Bio-Techne position peaked at $176K in Q1 2022.
  • 550 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.